An anxious mother asks you to evaluate two slowly growing asymptomatic nodules on the third and fourth fingers of her healthy 4-month-old son.
• What's the diagnosis?• How would you treat her?
Diagnosis: Infantile digital fibromatosis
IDF is exceptionally rare, with most nodules present at birth or developing in the first few months of life. Lesions are usually solitary, but a second fibroma may be noted at the time of diagnosis or subsequently. Although the etiology of infantile digital fibromatosis is unknown, a viral trigger has been suggested by the presence of characteristic inclusion bodies. However, viral cultures have proven to be negative. The localization of vimentin and muscle-specific actin in the tumor cells supports a myofibroblastic origin.
Histopathology and differential diagnosis
The tumor is nonencapsulated and composed of interlacing bundles of spindle cells and collagen, which extend from just beneath the epidermis through the dermis into the fat. Unique light microscopy features include the presence of intracytoplasmic eosinophilic inclusion bodies.2
Infantile digital fibromas can usually be clinically distinguished from other fibrous tumors of infancy by their characteristic location on the tip of the fingers and toes. Acral fibrokeratomas (including periungual fibromas) present as dome-shaped or elongated thin horns, with a 1-mm to 3-mm base and height of 1 cm to 1.5 cm arising from the periungual groove. Although these papules can present as solitary lesions in otherwise healthy children, the presence of multiple periungual fibromas should prompt a careful evaluation for other cutaneous and systemic markers of tuberous sclerosis.
Treatment
Infantile digital fibromas are benign, and many nodules resolve without intervention over two to three years. Local excision often leads to recurrence, so surgery is recommended only when lesions interfere with function or cause pain. Limited case reports demonstrate successful debulking of tumors without recurrence, using the Mohs micrographic surgery technique.3
ROYA SAMUELS is a third-year pediatrics resident at Schneider Children's Hospital, New Hyde Park, NY
References
1. Dabney KW, MacEwen GD, Davis NE: Recurring digital fibrous tumor of childhood: case report with long-term follow-up and review of the literature. J Pediatr Orthop 1986;6:612
2. Bhawan J, Bacchetta C, Joris I, et al: A myofibroblastic tumor. Infantile digital fibroma (recurrent digital fibrous tumor of childhood). Am J Pathol 1979;94:19
3. Albertini JG, Welsch MJ, Conger LA, et al. Infantile digital fibroma treated with mohs micrographic surgery. Dermatol Surg 2002;28:959
Recognize & Refer: Hemangiomas in pediatrics
July 17th 2019Contemporary Pediatrics sits down exclusively with Sheila Fallon Friedlander, MD, a professor dermatology and pediatrics, to discuss the one key condition for which she believes community pediatricians should be especially aware-hemangiomas.
Pz-cel granted FDA Priority Review to treat recessive dystrophic epidermolysis bullosa
November 28th 2023The FDA granted Priority Review to pz-cel following a phase 1/2 and a pivotal phase 3 study in which the treatment for recessive dystrophic epidermolysis bullosa (RDEB) demonstrated wound healing and pain reduction.
Worsening severity of AD in children associated with increased comorbidity onset risk
November 27th 2023Of patients in the atopic dermatitis (AD) cohort, 36.6% developed at least 1 comorbidity amid follow-up compared to 28.5% in the non-AD reference cohort, investigators of a Sweden, nationwide, population-based cohort study found.
Hematocrit levels in newborns: EPP vs DCC study reveals surprising findings
November 15th 2023A recent study in JAMA Network Open investigates the impact of extrauterine placental perfusion versus delayed cord clamping on hematocrit levels in newborns, shedding light on potential alternatives for optimizing infant outcomes during birth.
Preterm infant HRQOL: Long-term impacts and determinants
October 21st 2023A recent study was highlighted at the 2023 American Academy of Pediatrics National Conference & Exhibition that shed light on the long-term impact of very preterm birth on the health-related quality of life (HRQOL) of infants and identified key determinants.